PatchSiren cyber security CVE debrief
CVE-2026-60979 Oracle Corporation CVE debrief
AI-assisted PatchSiren debrief based on the supplied source corpus. The CVE record was published on 2026-07-21T22:18:31.217Z and has not been modified since then. This high-severity vulnerability affects Oracle Scripting product versions 12.2.3-12.2.15, allowing unauthenticated network attackers to potentially takeover the product. Evidence is limited to CVE and NVD details. Defenders should verify affected product deployments and review vendor guidance for patching and mitigation. The vulnerability has a CVSS 3.1 score of 8.1, indicating high severity for confidentiality, integrity, and availability impacts.
- Vendor
- Oracle Corporation
- Product
- Oracle Scripting
- CVSS
- HIGH 8.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-07-21
- Original CVE updated
- 2026-07-31
- Advisory published
- 2026-07-21
- Advisory updated
- 2026-07-31
Who should care
Oracle E-Business Suite users, Security teams, IT administrators, and operators managing Oracle Scripting product deployments should review and address this vulnerability. Vulnerability management and security teams should prioritize patching based on CVSS severity and potential impact on confidentiality, integrity, and availability.
Technical summary
CVE-2026-60979 is a high-severity vulnerability in Oracle Scripting product versions 12.2.3-12.2.15. The vulnerability allows unauthenticated attackers with network access via HTTP to compromise Oracle Scripting, potentially leading to product takeover. Successful attacks can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). The vulnerability is difficult to exploit and requires network access via HTTP. Oracle E-Business Suite users, Security teams, IT administrators, and operators managing Oracle Scripting product deployments should review and address this vulnerability.
Defensive priority
Oracle Scripting vulnerability allows unauthenticated network attackers to potentially takeover the product; apply vendor patches immediately.
Recommended defensive actions
- Apply Oracle patches for CVE-2026-60979
- Restrict network access to Oracle Scripting
- Monitor Oracle Scripting logs for suspicious activity
- Review compensating controls for exposed systems while remediation is scheduled and verified
- Check relevant monitoring, detection, and logs for exposed assets that need extra review
- Track exceptions, retest remediated assets, and close the item only after evidence is documented
- Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
Evidence notes
The CVE-2026-60979 vulnerability affects Oracle Scripting product versions 12.2.3-12.2.15. CVSS 3.1 score of 8.1 indicates high severity. Evidence is limited to CVE and NVD details. Defenders should verify affected product deployments and review vendor guidance for patching and mitigation. No additional information is available on exploitation or affected scope beyond vendor reports.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-60979 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-60979
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-60979 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-60979
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Mitigation or vendor reference
Unverified legacy reference
URL: https://www.oracle.com/security-alerts/cpujul2026.html
[email protected] - Vendor Advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.